RhApo2L/TRAIL

RhApo2L/TRAIL Uses, Dosage, Side Effects, Food Interaction and all others data.

RhApo2L/TRAIL has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.

Trade Name RhApo2L/TRAIL
Generic Dulanermin
Dulanermin Other Names Apo2L/TRAIL, Dulanermin, rhApo2L/TRAIL
Type
Formula C871H1329N243O260S4
Weight 19492.7851 Da
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
RhApo2L/TRAIL
RhApo2L/TRAIL

Innovators Monograph

You find simplified version here RhApo2L/TRAIL

*** Taking medicines without doctor's advice can cause long-term problems.
Share